Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,249 | 8,280 | 14,131 | 22,145 | 52,138 |
| Receivables | 7,550 | 7,320 | 6,057 | 5,665 | 4,523 |
| Inventories | 5,281 | 2,733 | 3,376 | 3,462 | 4,766 |
| TOTAL | $20,634 | $21,604 | $25,399 | $33,760 | $64,299 |
| Non-Current Assets | |||||
| PPE Net | 7,823 | 9,002 | 10,056 | 10,743 | 5,151 |
| Intangibles | 3,226 | 3,721 | 0 | 0 | 0 |
| Other Non-Current Assets | 12,499 | 13,045 | 17,501 | 18,729 | 20,070 |
| TOTAL | $23,548 | $25,768 | $27,558 | $29,472 | $25,220 |
| Total Assets | $44,182 | $47,372 | $52,956 | $63,232 | $89,519 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,500 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,869 | 3,340 | 3,802 | 1,655 | 2,805 |
| Accrued Expenses | 6,299 | 6,032 | 7,360 | 7,950 | 10,314 |
| TOTAL | $9,709 | $9,825 | $14,036 | $9,715 | $13,690 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,667 | 13,996 | 2,543 | 5,000 | N/A |
| Other Non-Current Liabilities | 11,903 | 12,444 | 12,897 | 13,142 | 13,251 |
| TOTAL | $28,570 | $26,440 | $15,440 | $18,142 | $13,251 |
| Total Liabilities | $38,279 | $36,265 | $29,475 | $27,857 | $26,941 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,700 | 62,500 | 54,294 | 43,663 | 43,506 |
| Common Shares | 63 | 55 | 54 | 44 | 44 |
| Retained earnings | -312,207 | -304,009 | -283,290 | -253,998 | -221,185 |
| Other shareholders' equity | -2,977 | 4,252 | 529 | 2,329 | 526 |
| TOTAL | $5,903 | $11,107 | $23,481 | $35,375 | $62,578 |
| Total Liabilities And Equity | $44,182 | $47,372 | $52,956 | $63,232 | $89,519 |